A drug with the SMILES C[N+]1(C)C2CC(OC(=O)[C@H](CO)c3ccccc3)CC1C1OC12.O=[N+]([O-])[O-] has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 8.035%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
C[N+]1(C)C2CC(OC(=O)[C@H](CO)c3ccccc3)CC1C1OC12.O=[N+]([O-])[O-]
C[N+]1(C)C2CC(OC(=O)[C@H](CO)c3ccccc3)CC1C1OC12.O=[N+]([O-])[O-]
(9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) (2S)-3-hydroxy-2-phenylpropanoate;nitrate